4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies
4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs.4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech - biologics, gene and cell therapy and bioinformatics.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 6, 2022
Entact Bio
|
Series A | $81M | Biopharma | — |
Sep 21, 2022
Carisma Therapeutics
|
Series C | $30M | Biotechnology | — |
Mar 1, 2021
Carisma Therapeutics
|
Series B | $12M | Biotechnology | — |
Jan 1, 2018
Autolus
|
Post-IPO Equity | — | Biopharma | — |
Jan 1, 2017
Cellectis
|
Post-IPO Equity | — | Biopharma | — |